Artelo Biosciences (ARTL) Net Income towards Common Stockholders (2014 - 2025)
Artelo Biosciences (ARTL) posted Net Income towards Common Stockholders of -$4.17 million for Q4 2025, compared with -$3.78 million a year earlier.
Powered by 
Analysis
Artelo Biosciences (ARTL) Net Income towards Common Stockholders (2014 - 2025) Analysis & Trends
For FY2025, Artelo Biosciences' Net Income towards Common Stockholders came in at -$12.88 million.
- In prior years, Artelo Biosciences' Net Income towards Common Stockholders was -$9.83 million in FY2024, -$9.29 million in FY2023, -$10.08 million in FY2022 and -$9.41 million in FY2021.
- The Q4 2025 figure stands as the lowest quarterly Net Income towards Common Stockholders in data going back to Q3 2014.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was -$3.12 million (Q3 2025), -$3.22 million (Q2 2025) and -$2.37 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Artelo Biosciences | 73,320.32 | -5.06 Mn | - | -4.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -4.17 Mn |
| Sep 30, 2025 | -3.12 Mn |
| Jun 30, 2025 | -3.22 Mn |
| Mar 31, 2025 | -2.37 Mn |
| Dec 31, 2024 | -3.78 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | -2.48 Mn |
| Dec 31, 2023 | -3.07 Mn |
| Sep 30, 2023 | -2.45 Mn |
| Jun 30, 2023 | -1.60 Mn |
| Mar 31, 2023 | -2.17 Mn |
| Dec 31, 2022 | -3.34 Mn |
| Sep 30, 2022 | -2.33 Mn |
| Jun 30, 2022 | -2.45 Mn |
| Mar 31, 2022 | -1.97 Mn |
| Nov 30, 2021 | -2.55 Mn |
| May 31, 2021 | -2.25 Mn |
| Feb 28, 2021 | -1.87 Mn |
| Nov 30, 2020 | -1.44 Mn |
API Access
Artelo Biosciences Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();